Last updated: 11/03/2018 14:02:37
Evaluation of the duration of oral combination therapy in Type 2 diabetes, prior to the initiation of insulin in the UK
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Evaluation of the duration of oral combination therapy in Type 2 diabetes, prior to the initiation of insulin in the UK
Trial description: Carry out the cost-effectiveness analysis of rosiglitazone on a population in line with the rosiglitazone license and using UK costs
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Cost-effectiveness of rosiglitazone
Timeframe: From literature
Secondary outcomes:
Not applicable
Interventions:
Enrollment:
7641
Primary completion date:
Not applicable
Observational study model:
Other
Time perspective:
Retrospective
Clinical publications:
Not applicable
Medical condition
Diabetes Mellitus, Type 2
Product
metformin, rosiglitazone, rosiglitazone/metformin
Collaborators
Not applicable
Study date(s)
October 2008 to June 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
Not applicable+ years
Accepts healthy volunteers
No
- Rosiglitazone Type II Diabetes studies
- Studies without the required outcome
Inclusion and exclusion criteria
Inclusion criteria:
- Rosiglitazone Type II Diabetes studies
Exclusion criteria:
- Studies without the required outcome
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2011-30-06
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website